JPS61191609A - 徐放性製剤 - Google Patents
徐放性製剤Info
- Publication number
- JPS61191609A JPS61191609A JP3233085A JP3233085A JPS61191609A JP S61191609 A JPS61191609 A JP S61191609A JP 3233085 A JP3233085 A JP 3233085A JP 3233085 A JP3233085 A JP 3233085A JP S61191609 A JPS61191609 A JP S61191609A
- Authority
- JP
- Japan
- Prior art keywords
- pva
- phase
- active substance
- concentration
- pharmacologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 230000003578 releasing effect Effects 0.000 title abstract 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 74
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 74
- 239000013543 active substance Substances 0.000 claims abstract description 24
- 230000008014 freezing Effects 0.000 claims abstract description 19
- 238000007710 freezing Methods 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 15
- 238000013268 sustained release Methods 0.000 claims description 10
- 239000012730 sustained-release form Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 abstract description 27
- 239000000017 hydrogel Substances 0.000 abstract description 20
- 238000006116 polymerization reaction Methods 0.000 abstract description 8
- 238000002425 crystallisation Methods 0.000 abstract description 7
- 230000008025 crystallization Effects 0.000 abstract description 7
- 238000007127 saponification reaction Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000000829 suppository Substances 0.000 abstract description 2
- 239000006190 sub-lingual tablet Substances 0.000 abstract 1
- 229940098466 sublingual tablet Drugs 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000003405 delayed action preparation Substances 0.000 description 15
- 230000008961 swelling Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 230000007423 decrease Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000013081 microcrystal Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000352 supercritical drying Methods 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3233085A JPS61191609A (ja) | 1985-02-20 | 1985-02-20 | 徐放性製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3233085A JPS61191609A (ja) | 1985-02-20 | 1985-02-20 | 徐放性製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61191609A true JPS61191609A (ja) | 1986-08-26 |
| JPH0511091B2 JPH0511091B2 (enrdf_load_stackoverflow) | 1993-02-12 |
Family
ID=12355928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3233085A Granted JPS61191609A (ja) | 1985-02-20 | 1985-02-20 | 徐放性製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61191609A (enrdf_load_stackoverflow) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5346935A (en) * | 1991-05-28 | 1994-09-13 | Takeda Chemical Industries, Ltd. | Hydrogel |
| US6447701B1 (en) | 1997-11-19 | 2002-09-10 | Ingo Heschel | Method for producing porous structures |
| JP2006523613A (ja) * | 2002-12-20 | 2006-10-19 | エスティ．ジェイムス アソシエイト エルエルシー／フェイバー リサーチ シリーズ | 徐放性医薬投与のための被覆粒子 |
| CN111606630A (zh) * | 2020-06-15 | 2020-09-01 | 陕西金磊混凝土有限公司 | 免蒸养高流动性混凝土及其制备方法 |
| JPWO2021205886A1 (enrdf_load_stackoverflow) * | 2020-04-10 | 2021-10-14 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5956446A (ja) * | 1982-09-24 | 1984-03-31 | Nippon Oil Co Ltd | ポリビニルアルコ−ル凍結ゲルの柔軟性低下法 |
-
1985
- 1985-02-20 JP JP3233085A patent/JPS61191609A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5956446A (ja) * | 1982-09-24 | 1984-03-31 | Nippon Oil Co Ltd | ポリビニルアルコ−ル凍結ゲルの柔軟性低下法 |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5346935A (en) * | 1991-05-28 | 1994-09-13 | Takeda Chemical Industries, Ltd. | Hydrogel |
| US6447701B1 (en) | 1997-11-19 | 2002-09-10 | Ingo Heschel | Method for producing porous structures |
| JP2006523613A (ja) * | 2002-12-20 | 2006-10-19 | エスティ．ジェイムス アソシエイト エルエルシー／フェイバー リサーチ シリーズ | 徐放性医薬投与のための被覆粒子 |
| JP2012072197A (ja) * | 2002-12-20 | 2012-04-12 | St James Associates Llc Faber Research Series | 徐放性医薬投与のための被覆粒子 |
| JPWO2021205886A1 (enrdf_load_stackoverflow) * | 2020-04-10 | 2021-10-14 | ||
| WO2021205886A1 (ja) * | 2020-04-10 | 2021-10-14 | 日本酢ビ・ポバール株式会社 | 結合剤 |
| CN115397469A (zh) * | 2020-04-10 | 2022-11-25 | 日本瓦姆&珀巴尔株式会社 | 粘合剂 |
| CN111606630A (zh) * | 2020-06-15 | 2020-09-01 | 陕西金磊混凝土有限公司 | 免蒸养高流动性混凝土及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0511091B2 (enrdf_load_stackoverflow) | 1993-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5346935A (en) | Hydrogel | |
| Yoshida et al. | A new temperature-sensitive hydrogel with α-amino acid group as side chain of polymer | |
| JP3134935B2 (ja) | 分岐ポリアンヒドリド | |
| US4164560A (en) | Systems for the controlled release of macromolecules | |
| Yu et al. | Novel composite double-layered dressing with improved mechanical properties and wound recovery for thermosensitive drug, Lactobacillus brevis | |
| EP2363104B1 (en) | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use | |
| EP1592405B1 (en) | Composition for chemoembolotherapy of solid tumors | |
| JPS619A (ja) | 活性薬剤濃度分布が改良一定放出のためのシグモイダル濃度勾配を含む活性薬剤含有ヒドロゲルデバイス、その製造方法および使用 | |
| Mongia et al. | Mucoadhesive poly (vinyl alcohol) hydrogels produced by freezing/thawing processes: applications in the development of wound healing systems | |
| JPH11510160A (ja) | 重合体薬剤配合物 | |
| Sowjanya et al. | Polymers used in the designing of controlled drug delivery system | |
| JP2006523733A5 (enrdf_load_stackoverflow) | ||
| CN108310452A (zh) | 一种温敏性葡聚糖基水凝胶及其制备方法 | |
| Graham et al. | Polymeric inserts and implants for the controlled release of drugs | |
| CN1145480C (zh) | 用于男性的避孕药 | |
| WO1998028364A1 (en) | Novel polymer gel composition and uses therefor | |
| JP3296579B2 (ja) | 成分放出が制御された合成物 | |
| WO2020163371A1 (en) | Methods for preventing and treating inflammation and inflammatory disease | |
| Shi et al. | Sustained release of alginate hydrogel containing antimicrobial peptide Chol-37 (F34-R) in vitro and its effect on wound healing in murine model of Pseudomonas aeruginosa infection | |
| JPS61191609A (ja) | 徐放性製剤 | |
| Bagri et al. | Evaluation of starch based cryogels as potential biomaterials for controlled release of antibiotic drugs | |
| US4781926A (en) | Transdermal therapeutic composition | |
| KR100891545B1 (ko) | 폴리이소프로필아크릴아미드가 고정화된 모노올레인큐빅상 및 그 제조방법 | |
| Taşkın Çakıcı | Nano TiO2-doped sodium alginate/hydroxypropyl methylcellulose synthesis of bionanocomposite membrane and its use in controlled release of anti-cancer drug 5-fluorouracil | |
| SK1795A3 (en) | Drug delivery device and method of this production |